IMID (Immune Mediated Inflammatory Diseases) BioResource
A recallable resource of participants with IMID diseases including rheumatoid arthritis, systemic lupus erythematosus and psoriasis with cross cutting co-morbidities.
- To recruit 16,000 participants nationally
- Collect samples and data on patients’ conditions
- Open sites across England
- Support research into shared biomarkers for IMID conditions, patient outcomes, and the links between health, genes and the environment.
About IMID BioResource
Immune-Mediated Inflammatory Diseases (IMIDs) are a wide group of common health conditions which cause inflammation in the body. IMIDs can affect different parts of the body, but all work by triggering the body's immune system to fight itself, causing inflammation. Common conditions include Rheumatoid Arthritis, Systemic Lupus Erythematosus (SLE), and Psoriasis.
The NIHR Manchester Biomedical Research Centre (BRC) is the lead centre for the NIHR IMID BioResource, in collaboration with NIHR Newcastle BRC and NIHR Leeds BRC. Together they aim to recruit 16,000 IMID patients, with recruitment being expanded across sites throughout England.